GDI - European Genomic Data Infrastructure

Last updated on 26-9-2023 by Marie Malingreau
Project duration:
November 1, 2022
October 31, 2026

In short

The Genomics Data Infrastructure (GDI) project enables access to genomic and related phenotypic and clinical data across Europe. We do this by establishing a federated, sustainable and secure infrastructure to access the data. It builds on the outputs of the Beyond 1 Million Genomes (B1MG) project and realises the ambition of the 1+Million Genomes (1+MG) initiative, which has a Belgian Mirror Group, coördinated by Sciesano.

More info on the project website

Project description

This project accomplishes the 1+MG initiative’s ambition to enable secure access to genomics and corresponding clinical data across Europe by creating data infrastructure. The project involves a consortium of partners from 20 European countries and facilitates a cross-border federated network of national genome collections for biomedical research and personalised medicine solutions. The GDI project aims to unlock a data network of over one million genome sequences for research and clinical reference. This creates unprecedented opportunities for transnational and multi-stakeholder actions in personalised medicine for common, rare and infectious diseases.

Authorised data users, such as clinicians, researchers and innovators, will be able to advance understanding of genomics for more precise and faster clinical decision-making, diagnostics, treatments and predictive medicine, and for improved public health measures to benefit European citizens, healthcare systems and the overall economy. 

As a critical component of Europe’s ambition to lead the integration of genomics into healthcare, the GDI project makes data accessible for research, clinical reference and policy development uses through three key ‘pillars’:

  1. Long term sustainability (governance model, legal framework, financial plan for the infrastructure)
  2. Infrastructure deployment (Interoperability of European data resources)
  3. Use cases (e.g. cancer and infectious disease data)

Sciensano, through the Belgian Cancer Centre, co-leads pillar 3 (use case on cancer) and contributes to the development of data-driven models for cancer research.



  • 44 partners
  • 20 countries

Belgian Partners

  • Sciensano
  • VIB
  • Interuniversity Microelectronics Centre (IMEC)


Work Package (WP) Leading Institute, Country
WP1 Coordination and support  EMBL, Germany
WP2 Long-term sustainability  UNILU, Luxemburg
WP3 Deployment of 1+MG national nodes UU, Sweden
WP4 European level operations UNILU, Luxemburg
WP5 Technical coordination and outread CSC, Finland
WP6 Data Management  HRI, The Netherlands
WP7 GDI use cases BSC, Spain
WP8 Application and innovation solution  BSC; Spain

Related projects

Technical information

Work Program DIGITAL-2021-CLOUD-A1-01 / Project: 101081813
Budget €40M
Lead Coordinator European Molecular Biology Labratory (EMBL), Germany 
Domain / Area European Health Data Space

Contact us 

Read more on the GDI project website

Service(s) working on this project


Financial Source

Associated Health Topics

QR code

QR code for this page URL